Clinical Trial Details
EORTC-1320
Back to Clinical Trials Database
Trabectedin for recurrent grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 10-Jul-2015 Date Step1 close: 20-Jul-2017 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 86 - All Groups: 86 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT02234050 |
| NCT number | NCT02234050 |
| EudraCT | 2014-002446-47 |
